Published in Biometrics on June 01, 2005
Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1. Mov Disord (2012) 1.49
Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. JAMA (2015) 1.37
Nonparametric bayes testing of changes in a response distribution with an ordinal predictor. Biometrics (2007) 1.37
A rank-based sample size method for multiple outcomes in clinical trials. Stat Med (2008) 1.07
Using global statistical tests in long-term Parkinson's disease clinical trials. Mov Disord (2009) 0.98
A Bayesian approach to joint analysis of multivariate longitudinal data and parametric accelerated failure time. Stat Med (2013) 0.98
Basal-like breast cancer displays distinct patterns of promoter methylation. Cancer Biol Ther (2010) 0.90
Bayesian multiple imputation for missing multivariate longitudinal data from a Parkinson's disease clinical trial. Stat Methods Med Res (2012) 0.89
Global rank tests for multiple, possibly censored, outcomes. Biometrics (2016) 0.80
A Weighted Rank-Sum Procedure for Comparing Samples with Multiple Endpoints. Stat Interface (2009) 0.78
Parkinson's disease severity and use of dopaminergic medications. Parkinsonism Relat Disord (2014) 0.76
Robust Bayesian hierarchical model using normal/independent distributions. Biom J (2015) 0.75
Formulating appropriate statistical hypotheses for treatment comparison in clinical trial design and analysis. Contemp Clin Trials (2014) 0.75
A rank test for bivariate time-to-event outcomes when one event is a surrogate. Stat Med (2016) 0.75
An optimal Wilcoxon-Mann-Whitney test of mortality and a continuous outcome. Stat Methods Med Res (2016) 0.75
Procedures for comparing samples with multiple endpoints. Biometrics (1984) 6.70
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol (2002) 4.60
The analysis of multiple endpoints in clinical trials. Biometrics (1987) 3.83
Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol (1998) 2.68
On the design and analysis of randomized clinical trials with multiple endpoints. Biometrics (1993) 2.13
Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results. Neurology (2001) 1.37
Closed testing procedures for group sequential clinical trials with multiple endpoints. Biometrics (1999) 1.28
Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials. MIRA Trial Group. Arthritis Rheum (1999) 1.27
Clinical differences among women with and without self-reported perimenstrual asthma. Ann Allergy Asthma Immunol (1998) 1.11
Global tests for multiple binary outcomes. Biometrics (1993) 1.00
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 12.92
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord (2008) 9.52
Measuring blood pressure for decision making and quality reporting: where and how many measures? Ann Intern Med (2011) 5.31
Effect of bar-code technology on the safety of medication administration. N Engl J Med (2010) 4.87
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord (2007) 3.86
Downwardly mobile: the accidental cost of being uninsured. Arch Surg (2009) 3.65
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA (2004) 3.51
Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Ann Surg (2008) 3.39
Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study. J Clin Oncol (2002) 3.25
Medical comorbidity in women and men with schizophrenia: a population-based controlled study. J Gen Intern Med (2006) 2.79
Implant-based breast reconstruction using acellular dermal matrix and the risk of postoperative complications. Plast Reconstr Surg (2010) 2.71
Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial. Arch Intern Med (2009) 2.62
Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin Infect Dis (2003) 2.54
Fall prevention in acute care hospitals: a randomized trial. JAMA (2010) 2.33
Massachusetts health reform and disparities in coverage, access and health status. J Gen Intern Med (2010) 2.24
Comparison of morbidity, functional outcome, and satisfaction following bilateral TRAM versus bilateral DIEP flap breast reconstruction. Plast Reconstr Surg (2010) 2.20
Mixed results in the safety performance of computerized physician order entry. Health Aff (Millwood) (2010) 2.19
Suture bicuspidization of the tricuspid valve versus ring annuloplasty for repair of functional tricuspid regurgitation: midterm results of 237 consecutive patients. J Thorac Cardiovasc Surg (2006) 1.95
Applying a phase II futility study design to therapeutic stroke trials. Stroke (2005) 1.89
Acculturation and diabetes among Hispanics: evidence from the 1999-2002 National Health and Nutrition Examination Survey. Public Health Rep (2006) 1.84
Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss. Circulation (2008) 1.80
Factors associated with the adoption of minimally invasive radical prostatectomy in the United States. J Urol (2012) 1.78
Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study. J Thorac Cardiovasc Surg (2006) 1.78
Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281. J Clin Oncol (2005) 1.72
Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis. J Rheumatol (2005) 1.67
Variation in use of head computed tomography by emergency physicians. Am J Med (2012) 1.64
Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med (2007) 1.62
Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members. Health Soc Work (2013) 1.59
Gulf War veterans with anxiety: prevalence, comorbidity, and risk factors. Epidemiology (2004) 1.57
Self-reported adherence versus pill count in Parkinson's disease: the NET-PD experience. Mov Disord (2007) 1.55
Improving quality of care for maternal and newborn health: prospective pilot study of the WHO safe childbirth checklist program. PLoS One (2012) 1.55
Percutaneous injury, blood exposure, and adherence to standard precautions: are hospital-based health care providers still at risk? Clin Infect Dis (2003) 1.53
Trends in primary care clinician perceptions of a new electronic health record. J Gen Intern Med (2009) 1.51
Outcomes and patient satisfaction following breast reconstruction with bilateral pedicled TRAM flaps in 105 consecutive patients. Plast Reconstr Surg (2010) 1.50
A policy-based intervention for the reduction of communication breakdowns in inpatient surgical care: results from a Harvard surgical safety collaborative. Ann Surg (2011) 1.49
A responsive outcome for Parkinson's disease neuroprotection futility studies. Ann Neurol (2005) 1.48
The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Ann Emerg Med (2005) 1.44
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. Int J Radiat Oncol Biol Phys (2005) 1.43
Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients. Ann Thorac Surg (2010) 1.42
Dietary magnesium and C-reactive protein levels. J Am Coll Nutr (2005) 1.40
Contemporary outcome measures in acute stroke research: choice of primary outcome measure and statistical analysis of the primary outcome in acute stroke trials. Stroke (2012) 1.39
Posttraumatic stress disorder and self-reported physical health status among U.S. Military personnel serving during the Gulf War period: a population-based study. Psychosomatics (2002) 1.33
Quasi-likelihood estimation for relative risk regression models. Biostatistics (2005) 1.31
Development of a measure to assess patient trust in medical researchers. Ann Fam Med (2006) 1.30
Prevalence of hypertension by duration and age at exposure to the stroke belt. J Am Soc Hypertens (2010) 1.29
Physician knowledge, attitudes and practices regarding a widely implemented guideline. J Eval Clin Pract (2002) 1.26
Age and race impact the association between BMI and CVD mortality in women. Public Health Rep (2007) 1.24
Addressing social determinants of health to improve access to early breast cancer detection: results of the Boston REACH 2010 Breast and Cervical Cancer Coalition Women's Health Demonstration Project. J Womens Health (Larchmt) (2009) 1.24
A comparison of missing data methods for hypothesis tests of the treatment effect in substance abuse clinical trials: a Monte-Carlo simulation study. Subst Abuse Treat Prev Policy (2008) 1.23
Benchmarking Veterans Affairs Medical Centers in the delivery of preventive health services: comparison of methods. Med Care (2002) 1.23
Correlates and predictors of colorectal cancer screening among male automotive workers. Cancer Epidemiol Biomarkers Prev (2007) 1.22
Sources of health information related to preventive health behaviors in a national study. Am J Prev Med (2010) 1.22
Application of beta regression to analyze ischemic stroke volume in NINDS rt-PA clinical trials. Neuroepidemiology (2011) 1.21
Fully specified bootstrap confidence intervals for the difference of two independent binomial proportions based on the median unbiased estimator. Stat Med (2009) 1.21
Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). J Neurol (2012) 1.20
A coronary heart disease risk score based on patient-reported information. Am J Cardiol (2007) 1.19
Recruiting older African American men to a cancer screening trial (the AAMEN Project). Gerontologist (2003) 1.16
Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes. Atherosclerosis (2006) 1.15
Statistical design considerations for pilot studies transitioning therapies from the bench to the bedside. J Transl Med (2004) 1.15
Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure. Nephrol Dial Transplant (2007) 1.14
Modafinil and cocaine interactions. Am J Drug Alcohol Abuse (2006) 1.14
Mucinous breast carcinoma: a large contemporary series. Am J Surg (2008) 1.13
Intention to be screened over time for colorectal cancer in male automotive workers. Cancer Epidemiol Biomarkers Prev (2003) 1.13
Organizational predictors of adherence to ambulatory care screening guidelines. Med Care (2002) 1.13
Recruitment of African Americans with type 2 diabetes to a randomized controlled trial using three sources. Ethn Health (2002) 1.12
Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival. Breast Cancer Res Treat (2008) 1.12
Examining the role of perceived susceptibility on colorectal cancer screening intention and behavior. Ann Behav Med (2010) 1.12
The patient satisfaction chasm: the gap between hospital management and frontline clinicians. BMJ Qual Saf (2012) 1.12
Retention of under-represented minorities in drug abuse treatment studies. Clin Trials (2009) 1.10
Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol (2005) 1.10
Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke. Stroke (2006) 1.10
Randomization in substance abuse clinical trials. Subst Abuse Treat Prev Policy (2006) 1.09
The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials. J Subst Abuse Treat (2008) 1.09
Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores. Mov Disord (2012) 1.07
A rank-based sample size method for multiple outcomes in clinical trials. Stat Med (2008) 1.07
Racial variation in clinical and immunological manifestations of systemic sclerosis. J Rheumatol (2006) 1.07
Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience. Arch Neurol (2009) 1.06
Comparison of quantitative educational metrics between integrated and independent plastic surgery residents. Plast Reconstr Surg (2008) 1.05
Nonprescribed antimicrobial drugs in Latino community, South Carolina. Emerg Infect Dis (2005) 1.05
Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy? J Surg Oncol (2007) 1.05
Causes and patterns of readmissions in patients with common comorbidities: retrospective cohort study. BMJ (2013) 1.04
Analysis of clustered and interval censored data from a community-based study in asthma. Stat Med (2004) 1.04
Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency. Clin Gastroenterol Hepatol (2005) 1.04
Likelihood methods for binary responses of present components in a cluster. Biometrics (2010) 1.03
Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials. Clin Trials (2005) 1.02
Fall TIPS: strategies to promote adoption and use of a fall prevention toolkit. AMIA Annu Symp Proc (2009) 1.01
Organizational and provider characteristics fostering smoking cessation practice guideline adherence: an empirical look. J Ambul Care Manage (2002) 1.00
Differences in cardiovascular disease mortality associated with body mass between Black and White persons. Am J Public Health (2007) 0.98
Caffeine and progression of Parkinson disease. Clin Neuropharmacol (2008) 0.98
Using global statistical tests in long-term Parkinson's disease clinical trials. Mov Disord (2009) 0.98
What if the federal government negotiated pharmaceutical prices for seniors? An estimate of national savings. J Gen Intern Med (2008) 0.98
Effectiveness of a nationally implemented smoking cessation guideline on provider and patient practices. Prev Med (2003) 0.97
Factors influencing physician referrals of patients to clinical trials. J Natl Med Assoc (2008) 0.97